14 results on '"Cuozzo C"'
Search Results
2. Erratum: Correction: DNA Damage, Homology-Directed Repair, and DNA Methylation (PLoS genetics (2007) 3 7 (e110))
- Author
-
Cuozzo C., Porcellini A., Angrisano T., Morano A., Lee B., Pardo A. D., Messina S., Iuliano R., Fusco A., Santillo M. R., Muller M. T., Chiariotti L., Gottesman M. E., Avvedimento E. V., Cuozzo, C., Porcellini, A., Angrisano, T., Morano, A., Lee, B., Pardo, A. D., Messina, S., Iuliano, R., Fusco, A., Santillo, M. R., Muller, M. T., Chiariotti, L., Gottesman, M. E., and Avvedimento, E. V.
- Abstract
[This corrects the article DOI: 10.1371/journal.pgen.0030110.].
- Published
- 2017
3. Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK1/2. Amplification of ROS and Ras in systemic sclerosis fibroblasts
- Author
-
Svegliati S, Cancello R, Sambo P, Luchetti M, Paroncini P, Orlandini G, Discepoli G, Paterno R, Cuozzo C, Cassano S, Avvedimento EV, Gabrielli A., SANTILLO, MARIAROSARIA, Svegliati, S, Cancello, R, Sambo, P, Luchetti, M, Paroncini, P, Orlandini, G, Discepoli, G, Paterno, R, Santillo, Mariarosaria, Cuozzo, C, Cassano, S, Avvedimento, VITTORIO ENRICO, Gabrielli, A., and Avvedimento, Ev
- Subjects
Mitogen-Activated Protein Kinase 1 ,Platelet-Derived Growth Factor ,Mitogen-Activated Protein Kinase 3 ,Scleroderma, Systemic ,Time Factors ,ERK1/2 ,Reverse Transcriptase Polymerase Chain Reaction ,Immunoblotting ,MAP Kinase Kinase 1 ,Apoptosis ,Fibroblasts ,Blotting, Northern ,Flow Cytometry ,Transfection ,Models, Biological ,Phenotype ,Microscopy, Fluorescence ,Reactive Oxygen Species (ROS) ,ras Proteins ,Humans ,RNA, Messenger ,Reactive Oxygen Species ,Oxidation-Reduction ,Cells, Cultured ,DNA Damage - Abstract
The levels of Ras proteins in human primary fibroblasts are regulated by PDGF (platelet-derived growth factor). PDGF induced post-transcriptionally Ha-Ras by stimulating reactive oxygen species (ROS) and ERK1/2. Activation of ERK1/2 and high ROS levels stabilize Ha-Ras protein, by inhibiting proteasomal degradation. We found a remarkable example in vivo of amplification of this circuitry in fibroblasts derived from systemic sclerosis ( scleroderma) lesions, producing vast excess of ROS and undergoing rapid senescence. High ROS, Ha-Ras, and active ERK1/2 stimulated collagen synthesis, DNA damage, and accelerated senescence. Conversely ROS or Ras inhibition interrupted the signaling cascade and restored the normal phenotype. We conclude that in primary fibroblasts stabilization of Ras protein by ROS and ERK1/2 amplifies the response of the cells to growth factors and in systemic sclerosis represents a critical factor in the onset and progression of the disease.
- Published
- 2005
4. Differential phosphorylation of c-Jun and JunD in response to the epidermal growth factor is determined by the structure of MAPK targeting sequences
- Author
-
Vinciguerra M, Vivacqua A, Fasanella G, Gallo A, Cuozzo C, Morano A, Maggiolini M, and Musti AM.
- Subjects
integumentary system - Abstract
MAPK phosphorylation of various substrates is mediated by the presence of docking sites, including the D domain and the DEF motif. Depending on the number and sequences of these domains, substrates are phosphorylated by specific subsets of MAPKs. For example, a D domain targets JNK to c-Jun, whereas a DEF motif is required for ERK phosphorylation of c-Fos. JunD, in contrast, contains both D and DEF domains. Here we show that these motifs mediate JunD phosphorylation in response to either ERK or JNK activation. An intact D domain is required for phosphorylation and activation of JunD by both subtypes of MAPK. The DEF motif acts together with the D domain to elicit efficient phosphorylation of JunD in response to the epidermal growth factor (EGF) but has no function on JunD phosphorylation and activation by JNK signaling. Furthermore, we show that conversion of a c-Jun sequence to a canonical DEF domain, as it is present in JunD, elicits c-Jun activation in response to EGF. Our results suggest that evolution of a particular modular system of MAPK targeting sequences has determined a differential response of JunD and c-Jun to ERK activation
- Published
- 2004
5. Menin uncouples Elk-1, Jun D and cjun phosphorylation from MAP kinase activation
- Author
-
Gallo A., Cuozzo C., Esposito I., Maggiolini M., Bonfiglio D., Vivacqua A., Garramone M., Weiss C. Bohmann D., and Musti A.M.
- Published
- 2002
6. p85 regulatory subunit of PI3K mediates cAMP–PKA and estrogens biological effects on growth and survival
- Author
-
Cosentino, C, primary, Di Domenico, M, additional, Porcellini, A, additional, Cuozzo, C, additional, De Gregorio, G, additional, Santillo, M R, additional, Agnese, S, additional, Di Stasio, R, additional, Feliciello, A, additional, Migliaccio, A, additional, and Avvedimento, E V, additional
- Published
- 2006
- Full Text
- View/download PDF
7. DNA oxidation as triggered by H3K9me2 demethylation drives estrogen-induced gene expression
- Author
-
Antonio Malorni, Lorenzo Chiariotti, Bruno Perillo, Concetta Cuozzo, Ciro Abbondanza, Silvana Sacchetti, Alessandra Bertoni, Enrico V. Avvedimento, Annarita Sasso, Maria Neve Ombra, Perillo, B., Ombra, M., Bertoni, A., Cuozzo, C., Sacchetti, S., Sasso, A., Chiariotti, L., Malorni, A., Abbondanza, Ciro, Avvedimento, E., Perillo, B, Ombra, Mn, Bertoni, A, Cuozzo, C, Sacchetti, S, Sasso, A, Chiariotti, Lorenzo, Malorni, A, Abbondanza, C, and Avvedimento, VITTORIO ENRICO
- Subjects
Histone-modifying enzymes ,Guanine ,DNA Repair ,Transcription, Genetic ,Response element ,Biology ,Methylation ,DNA Glycosylases ,Histones ,Epigenetics of physical exercise ,efficient transcription ,Cell Line, Tumor ,Histone methylation ,Humans ,histone methylation ,Promoter Regions, Genetic ,Cells, Cultured ,Histone Demethylases ,Multidisciplinary ,General transcription factor ,Estradiol ,Lysine ,Pioneer factor ,Estrogen Receptor alpha ,Oxidoreductases, N-Demethylating ,DNA ,Hydrogen Peroxide ,Molecular biology ,Chromatin ,Genes, bcl-2 ,DNA-Binding Proteins ,DNA demethylation ,DNA Topoisomerases, Type II ,Enhancer Elements, Genetic ,Gene Expression Regulation ,Nucleic Acid Conformation ,RNA Polymerase II ,Oxidation-Reduction ,DNA Damage - Abstract
Modifications at the N-terminal tails of nucleosomal histones a re re quired for effici ent transcription in vivo. W e a nalyzed how H3 histone methylation and demethylation cont rol e xpression of estrog en-responsive g enes and s how t hat a DNA-bound e strog en r ecep tor directs transcription b y p articipa t ing i n be n ding chromati n t o contact the RNA polyme rase II re crui ted t o t he p r omote r. This process i s driven by r eceptor-targeted demethyl atio n o f H 3 l ysine 9 at both enhancer and p romoter sites and is achieved by activation of re sident LSD1 demethylase. Localized d emethylation produces hydrogen peroxide, which modifies the s urrounding DNA and recruits 8-oxog uanine–DNA glycosylase 1and topoisomeraseIIb, t riggering chromatin and DNA c onfo rmational c hanges that are e ssential for e st rogen-induced t ranscr iption. O ur data show a s trategy t hat uses c ontrolled D NA damage and repair to guide prod uctive tra n scription.
- Published
- 2008
- Full Text
- View/download PDF
8. p85 regulatory subunit of PI3K mediates cAMP–PKA and estrogens biological effects on growth and survival
- Author
-
R Di Stasio, Anna Rita Migliaccio, Concetta Cuozzo, M. Di Domenico, Mariarosaria Santillo, Savina Agnese, Enrico V. Avvedimento, Antonio Porcellini, Antonio Feliciello, C Cosentino, G De Gregorio, C., Cosentino, M., DI DOMENICO, Porcellini, Antonio, C., Cuozzo, G., DE GREGORIO, Santillo, Mariarosaria, S., Agnese, R., DI STASIO, Feliciello, Antonio, A., Migliaccio, Avvedimento, VITTORIO ENRICO, Cosentino, C, DI DOMENICO, Marina, Porcellini, A, Cuozzo, C, DE GREGORIO, G, Santillo, Mr, Agnese, S, DI STASIO, R, Feliciello, A, Migliaccio, Antimo, and Avvedimento, Ev
- Subjects
Cancer Research ,Cell Survival ,growth ,PI3K ,Proto-Oncogene Proteins p21(ras) ,Phosphatidylinositol 3-Kinases ,Growth factor receptor ,cAMP ,Cyclic AMP ,Serine ,Genetics ,Animals ,Humans ,Anoikis ,Phosphorylation ,Protein kinase A ,Molecular Biology ,Cells, Cultured ,Cell Proliferation ,Platelet-Derived Growth Factor ,biology ,Kinase ,G1 Phase ,Estrogens ,Cyclic AMP-Dependent Protein Kinases ,Cell biology ,p21Ras ,Biochemistry ,Cytoprotection ,Mutation ,biology.protein ,p21Ra ,Signal transduction ,CREB1 ,hormones, hormone substitutes, and hormone antagonists ,Platelet-derived growth factor receptor ,Signal Transduction - Abstract
Cyclic adenosine 3'5' monophosphate (cAMP) and protein kinase A (PKA) cooperate with phosphatidylinositol 3' kinase (PI3K) signals in the control of growth and survival. To determine the molecular mechanism(s) involved, we identified and mutagenized a specific serine (residue 83) in p85alpha(PI3K), which is phosphorylated in vivo and in vitro by PKA. Expression of p85alpha(PI3K) mutants (alanine or aspartic substitutions) significantly altered the biological responses of the cells to cAMP. cAMP protection from anoikis was reduced in cells expressing the alanine version p85alpha(PI3K). These cells did not arrest in G1 in the presence of cAMP, whereas cells expressing the aspartic mutant p85D accumulated in G1 even in the absence of cAMP. S phase was still efficiently inhibited by cAMP in cells expressing both mutants. The binding of PI3K to Ras p21 was greatly reduced in cells expressing p85A in the presence or absence of cAMP. Conversely, expression of the aspartic mutant stimulated robustly the binding of PI3K to p21 Ras in the presence of cAMP. Mutation in the Ser 83 inhibited cAMP, but not PDGF stimulation of PI3K. Conversely, the p85D aspartic mutant amplified cAMP stimulation of PI3K activity. Phosphorylation of Ser 83 by cAMP-PKA in p85alpha(PI3K) was also necessary for estrogen signaling as expression of p85A or p85D mutants inhibited or amplified, respectively, the binding of estrogen receptor to p85alpha and AKT phosphorylation induced by estrogens. The data presented indicate that: (1) phosphorylation of Ser 83 in p85alpha(PI3K) is critical for cAMP-PKA induced G1 arrest and survival in mouse 3T3 fibroblasts; (2) this site is necessary for amplification of estrogen signals by cAMP-PKA and related receptors. Finally, these data suggest a general mechanism of PI3K regulation by cAMP, operating in various cell types and under different conditions.
- Published
- 2007
9. DNA Damage, Homology-Directed Repair, and DNA Methylation
- Author
-
Samantha Messina, Mark T. Muller, Antonio Porcellini, Concetta Cuozzo, Enrico V. Avvedimento, Mariarosaria Santillo, Alfredo Fusco, Bongyong Lee, Annalisa Morano, Rodolfo Iuliano, Alba Di Pardo, Tiziana Angrisano, Max E. Gottesman, Lorenzo Chiariotti, C, Cuozzo, A, Porcellini, T, Angrisano, A, Morano, B, Lee, Ad, Pardo, Messina, S., R, Iuliano, A, Fusco, Mr, Santillo, Mt, Muller, L, Chiariotti, Me, Gottesman, Ev, Avvedimento, C., Cuozzo, Porcellini, A, Angrisano, Tiziana, Morano, A, Lee, B, Pardo, Ad, Messina, S, Iuliano, R, Fusco, Alfredo, Santillo, Mr, Muller, Mt, Chiariotti, Lorenzo, Gottesman, Me, Avvedimento, VITTORIO ENRICO, Cuozzo, C, Porcellini, Antonio, Di Pardo, A, and Avvedimento, Ev
- Subjects
Cancer Research ,DNA Repair ,Gene Expression ,Loss of Heterozygosity ,Mice ,Histone methylation ,DNA Breaks, Double-Stranded ,DNA (Cytosine-5-)-Methyltransferases ,RNA-Directed DNA Methylation ,Genetics (clinical) ,Epigenomics ,Mammals ,Recombination, Genetic ,Homo (human) ,Methylation ,Mus (mouse) ,Chromatin ,Recombinant Proteins ,In Vitro ,DNA methylation ,Research Article ,DNA (Cytosine-5-)-Methyltransferase 1 ,lcsh:QH426-470 ,DNA damage ,DNA repair ,Green Fluorescent Proteins ,Biology ,Transfection ,Cell Line ,Genetics ,Animals ,Humans ,Gene Silencing ,RNA, Messenger ,Thyroid Neoplasms ,Molecular Biology ,Ecology, Evolution, Behavior and Systematics ,DNA Primers ,Base Sequence ,Models, Genetic ,Correction ,Cell Biology ,DNA Methylation ,Molecular biology ,lcsh:Genetics ,repair ,CpG Islands ,methylation ,In vitro recombination ,DNA Damage ,HeLa Cells - Abstract
To explore the link between DNA damage and gene silencing, we induced a DNA double-strand break in the genome of Hela or mouse embryonic stem (ES) cells using I-SceI restriction endonuclease. The I-SceI site lies within one copy of two inactivated tandem repeated green fluorescent protein (GFP) genes (DR-GFP). A total of 2%–4% of the cells generated a functional GFP by homology-directed repair (HR) and gene conversion. However, ~50% of these recombinants expressed GFP poorly. Silencing was rapid and associated with HR and DNA methylation of the recombinant gene, since it was prevented in Hela cells by 5-aza-2′-deoxycytidine. ES cells deficient in DNA methyl transferase 1 yielded as many recombinants as wild-type cells, but most of these recombinants expressed GFP robustly. Half of the HR DNA molecules were de novo methylated, principally downstream to the double-strand break, and half were undermethylated relative to the uncut DNA. Methylation of the repaired gene was independent of the methylation status of the converting template. The methylation pattern of recombinant molecules derived from pools of cells carrying DR-GFP at different loci, or from an individual clone carrying DR-GFP at a single locus, was comparable. ClustalW analysis of the sequenced GFP molecules in Hela and ES cells distinguished recombinant and nonrecombinant DNA solely on the basis of their methylation profile and indicated that HR superimposed novel methylation profiles on top of the old patterns. Chromatin immunoprecipitation and RNA analysis revealed that DNA methyl transferase 1 was bound specifically to HR GFP DNA and that methylation of the repaired segment contributed to the silencing of GFP expression. Taken together, our data support a mechanistic link between HR and DNA methylation and suggest that DNA methylation in eukaryotes marks homologous recombined segments., Author Summary Genomic DNA can be modified by cytosine methylation. This epigenetic modification is layered on the primary genetic information and can silence the affected gene. Epigenetic modification has been implicated in cancer and aging. To date, the primary cause and the mechanism leading to DNA methylation are not known. By using a sophisticated genetic system, we have induced a single break in the double helix of the genomes of mouse or human cells. This rupture was repaired by a very precise mechanism: the damaged chromosome pairs and retrieves genetic information from an undamaged and homologous DNA partner. This homology-directed repair was marked in half of the repaired molecules by de novo methylation of cytosines flanking the cut. As a direct consequence, the gene in these repaired molecules was silenced. In the remaining molecules, the recombinant DNA was undermethylated and expressed the reconstituted gene. Since homology-directed repair may duplicate or delete genetic information, epigenetic modification of repaired DNA represents a powerful evolutionary force. If the expression of the repaired gene is harmful, only cells inheriting the silenced copy will survive. Conversely, if the function of the repaired gene is beneficial, cells inheriting the under-methylated copy will have a selective advantage.
- Published
- 2007
- Full Text
- View/download PDF
10. SwissBioisostere 2021: updated structural, bioactivity and physicochemical data delivered by a reshaped web interface.
- Author
-
Alessandro C, Antoine D, Marta A S P, Olivier M, and Vincent Z
- Subjects
- Humans, Small Molecule Libraries classification, User-Computer Interface, Computational Chemistry trends, Databases, Factual, Drug Discovery trends, Small Molecule Libraries chemistry
- Abstract
At several stages of drug discovery, bioisosteric replacement is a common and efficient practice to find new bioactive chemotypes or to optimize series of molecules toward drug candidates. The critical steps consisting in selecting which molecular moiety should be replaced by which other chemical fragment is often relying on the expertise of specialists. Nowadays, valuable support can be obtained through the wealth of dedicated structural and knowledge data. The present article details the update of SwissBioisostere, a database of >25 millions of unique molecular replacements with data on bioactivity, physicochemistry, chemical and biological contexts extracted from the literature and related resources. The content of the database together with analysis and visualization capacities is freely available at www.swissbioisostere.ch., (© The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research.)
- Published
- 2022
- Full Text
- View/download PDF
11. Oxidative Stress in the Early Stage of Psychosis.
- Author
-
Ventriglio A, Bellomo A, Donato F, Iris B, Giovanna V, Dario DS, Edwige C, Di Gioia Ilaria, Pettorruso M, Perna G, Valchera A, and De Berardis D
- Subjects
- Antioxidants metabolism, Glutathione metabolism, Humans, Lipid Peroxides metabolism, Nitric Oxide metabolism, Psychotic Disorders drug therapy, Receptors, Glutamate metabolism, Oxidative Stress, Psychotic Disorders metabolism
- Abstract
Background: In the past few decades, increasing evidence in the literature has appeared describing the role of the antioxidant defense system and redox signaling in the multifactorial pathophysiology of psychosis. It is of interest to clinicians and researchers alike that abnormalities of the antioxidant defense system are associated with alterations of cellular membranes, immune functions and neurotransmission, all of which have some clinical implications., Methods: This narrative review summarizes the evidence regarding oxidative stress in the early stages of psychosis. We included 136 peer-reviewed articles published from 2007 to 2020 on PubMed EMBASE, The Cochrane Library and Google Scholar., Results: Patients affected by psychotic disorders show a decreased level of non-enzymatic antioxidants, an increased level of lipid peroxides, nitric oxides, and a homeostatic imbalance of purine catabolism. In particular, a significantly reduced antioxidant defense has been described in the early onset first episode of psychosis, including reduced levels of glutathione. Also, it has been shown that a decreased basal low-antioxidant capacity correlates with cognitive deficits and negative symptoms, mostly related to glutamate-receptor hypofunction. In addition, atypical antipsychotic drugs seem to show significant antioxidant activity. These factors are critical in order to treat cases of first-onset psychosis effectively., Conclusion: This systematic review indicates the importance that must be given to anti-oxidant defense systems., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)
- Published
- 2021
- Full Text
- View/download PDF
12. Correction: DNA Damage, Homology-Directed Repair, and DNA Methylation.
- Author
-
Cuozzo C, Porcellini A, Angrisano T, Morano A, Lee B, Pardo AD, Messina S, Iuliano R, Fusco A, Santillo MR, Muller MT, Chiariotti L, Gottesman ME, and Avvedimento EV
- Abstract
[This corrects the article DOI: 10.1371/journal.pgen.0030110.].
- Published
- 2017
- Full Text
- View/download PDF
13. Lack of an effect of standard and supratherapeutic doses of linezolid on QTc interval prolongation.
- Author
-
Damle B, Labadie RR, Cuozzo C, Alvey C, Choo HW, Riley S, and Kirby D
- Subjects
- Acetamides therapeutic use, Adult, Aza Compounds adverse effects, Aza Compounds therapeutic use, Cross-Over Studies, Double-Blind Method, Drug Administration Schedule, Female, Fluoroquinolones, Gram-Positive Bacterial Infections drug therapy, Humans, Linezolid, Male, Middle Aged, Moxifloxacin, Oxazolidinones therapeutic use, Quinolines adverse effects, Quinolines therapeutic use, Young Adult, Acetamides adverse effects, Anti-Infective Agents adverse effects, Arrhythmias, Cardiac chemically induced, Oxazolidinones adverse effects
- Abstract
A double-blind, placebo-controlled, four-way crossover study was conducted in 40 subjects to assess the effect of linezolid on corrected QT (QTc) interval prolongation. Time-matched, placebo-corrected QT intervals were determined predose and at 0.5, 1 (end of infusion), 2, 4, 8, 12, and 24 h after intravenous dosing of linezolid 600 and 1,200 mg. Oral moxifloxacin at 400 mg was used as an active control. The pharmacokinetic profile of linezolid was also evaluated. At each time point, the upper bound of the 90% confidence interval (CI) for placebo-corrected QTcF values (i.e., QTc values adjusted for ventricular rate using the correction methods of Fridericia) for linezolid 600 and 1,200-mg doses were <10 ms, which indicates an absence of clinically significant QTc prolongation. At 2 and 4 h after the moxifloxacin dose, corresponding to the population T(max), the lower bound of the two-sided 90% CI for QTcF when comparing moxifloxacin to placebo was >5 ms, indicating that the study was adequately sensitive to assess QTc prolongation. The pharmacokinetic profile of linezolid at 600 mg was consistent with previous observations. Systemic exposure to linezolid increased in a slightly more than dose-proportional manner at supratherapeutic doses, but the degree of nonlinearity was small. At a supratherapeutic single dose of 1,200 mg of linezolid, no treatment-related increase in adverse events was seen compared to 600 mg of linezolid, and no clinically meaningful effects on vital signs and safety laboratory evaluations were noted.
- Published
- 2011
- Full Text
- View/download PDF
14. Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation.
- Author
-
Gallo A, Cuozzo C, Esposito I, Maggiolini M, Bonofiglio D, Vivacqua A, Garramone M, Weiss C, Bohmann D, and Musti AM
- Subjects
- Animals, Binding Sites, Chloramphenicol O-Acetyltransferase metabolism, Down-Regulation, Glutathione Transferase, HeLa Cells, Humans, Immunoblotting, MAP Kinase Kinase 4, Mitogen-Activated Protein Kinase Kinases pharmacology, Mitogen-Activated Protein Kinases pharmacology, Phosphorylation, Plasmids, Promoter Regions, Genetic, Protein Serine-Threonine Kinases pharmacology, Proto-Oncogene Proteins genetics, Proto-Oncogene Proteins c-fos metabolism, Proto-Oncogene Proteins c-jun genetics, Transcription Factors genetics, Transcription Factors metabolism, Transcriptional Activation, ets-Domain Protein Elk-1, Calcium-Calmodulin-Dependent Protein Kinases metabolism, DNA-Binding Proteins, JNK Mitogen-Activated Protein Kinases, MAP Kinase Kinase Kinase 1, Neoplasm Proteins pharmacology, Proto-Oncogene Proteins metabolism, Proto-Oncogene Proteins c-jun metabolism, Transcription Factor AP-1 metabolism
- Abstract
Menin, a nuclear protein encoded by the tumor suppressor gene MEN1, interacts with the AP-1 transcription factor JunD and inhibits its transcriptional activity. In addition, overexpression of Menin counteracts Ras-induced tumorigenesis. We show that Menin inhibits ERK-dependent phosphorylation and activation of both JunD and the Ets-domain transcription factor Elk-1. We also show that Menin represses the inducible activity of the c-fos promoter. Furthermore, Menin expression inhibits Jun N-terminal kinase (JNK)-mediated phosphorylation of both JunD and c-Jun. Kinase assays show that Menin overexpression does not interfere with activation of either ERK2 or JNK1, suggesting that Menin acts at a level downstream of MAPK activation. An N-terminal deletion mutant of Menin that cannot inhibit JunD phosphorylation by JNK, can still repress JunD phosphorylation by ERK2, suggesting that Menin interferes with ERK and JNK pathways through two distinct inhibitory mechanisms. Taken together, our data suggest that Menin uncouples ERK and JNK activation from phosphorylation of their nuclear targets Elk-1, JunD and c-Jun, hence inhibiting accumulation of active Fos/Jun heterodimers. This study provides new molecular insights into the tumor suppressor function of Menin and suggests a mechanism by which Menin may interfere with Ras-dependent cell transformation and oncogenesis.
- Published
- 2002
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.